Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)

NCT03260868 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Due to "prolonged low participant recruitment"

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Insulin glargine, 300 units per milliliter (U/mL)
DRUG: Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra)

Sponsor

Sanofi